These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20642487)

  • 1. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
    Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM; Palmer RH; Gendreau RM; Chen W
    Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
    Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
    J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
    Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
    Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
    Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
    Mease PJ; Palmer RH; Wang Y
    J Clin Rheumatol; 2014 Jun; 20(4):195-202. PubMed ID: 24847745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
    Arnold LM; Bateman L; Palmer RH; Lin Y
    Pediatr Rheumatol Online J; 2015 Jun; 13():27. PubMed ID: 26112278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
    Pae CU; Masand PS; Marks DM; Krulewicz S; Han C; Peindl K; Mannelli P; Patkar AA
    World J Biol Psychiatry; 2009; 10(4 Pt 2):435-41. PubMed ID: 19382010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
    Branco JC; Zachrisson O; Perrot S; Mainguy Y;
    J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
    Arnold LM; Palmer RH; Ma Y
    Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
    Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.